CR | Relapse | |
---|---|---|
(n=14) | (n=11) | |
Duration of TAC use (median (range)) (days) | 411 (121–995) | 405 (63–962) |
Cessation of TAC within 6 months | 4 | 3 |
Maintenance therapy with TAC | ||
IM+5-ASA | 13 | 7 |
IM | 1 | 0 |
5-ASA | 0 | 4 |
Numbers of patients are shown unless specified.
5-ASA, 5-aminosalicylate; CR, clinical remission; IM, immunomodulators; TAC, tacrolimus.